Bibliography

Export 35 results:
Filters: Keyword is Transplantation Immunology  [Clear All Filters]
2011
Gala-Lopez BL, Senior PA, Koh A, Kashkoush SM, Kawahara T, Kin T, et al. Late cytomegalovirus transmission and impact of T-depletion in clinical islet transplantation. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons//Am J Transplant. 2011;11(12):2708-14.
2010
Patel M, Carby M, Rice A, Cummins D, Banner NR. Medium-term outcome of an ABO incompatible lung transplant. Am J Transplant. 2010;10(3):702-3.
2005
Buell JF, Gross TG, Woodle ES. Malignancy after transplantation. Transplantation. 2005;80(2 Suppl):S254-64.
2004
Trofe J, Beebe TM, Buell JF, Hanaway MJ, First MR, Alloway RR, et al. Posttransplant malignancy. Prog Transplant. 2004;14(3):193-200.
2002
Husted TL, Buell JF, Hanaway MJ, Trofe J, Beebe T, Gross T, et al. De novo sarcomas in solid organ transplant recipients. Transplant Proc. 2002;34(5):1786-7.
Ades L, Guardiola P, Socie G. Second malignancies after allogeneic hematopoietic stem cell transplantation: new insight and current problems. Blood Rev. 2002;16(2):135-46.
Fabrizio F, Bunnapradist S, Martin P. Transplanting kidneys from donors with prior hepatitis B infection: one response to the organ shortage. J Nephrol. 2002;15(6):605-13.
2000
Sternberg AJ, Lee G, Croxton T, Mundy N, Morris P, Littlewood TJ, et al. Severe haemolysis after an ABO unmatched kidney transplant - a nonsecretor transplanted from a donor with high anti-A titre. Transfus Med. 2000;10(1):87-9.
1998
Suranyi MG, Hogan PG, Falk MC, Axelsen RA, Rigby R, Hawley C, et al. Advanced donor-origin melanoma in a renal transplant recipient: immunotherapy, cure, and retransplantation. Transplantation. 1998;66(5):655-661.
1996
Jacobs LB, Shirey RS, Ness PM. Hemolysis due to the simultaneous occurrence of passenger lymphocyte syndrome and a delayed hemolytic transfusion reaction in a liver transplant patient. Archives of pathology & laboratory medicine//Arch Pathol Lab Med. 1996;120(7):684-6.
1994
Penn I. De novo tumors in pediatric organ transplant recipients. Transplant Proc. 1994;26(1):1-2.
1981
Penn I. The price of immunotherapy. Curr Probl Surg. 1981;18(11):681-751.
1978
Friedlaender GE, Sell KW, Strong DM. Bone allograft antigenicity in an experimental model and in man. Acta Med Pol. 1978;19(40575):197-205.
Penn I. Development of cancer in transplantation patients. Adv Surg. 1978;12:155-91.
Briner J, Eckert J, Frei D, Largiadèr F, Binswanger U, Blumberg A. [Strongyloidiasis following kidney transplantation]. Schweiz Med Wochenschr. 1978;108(42):1632-7.
1975
Wilson RE, Penn I. Fate of tumors transplanted with a renal allograft. Transplant Proc. 1975;7(2):327-31.
Penn I. The incidence of malignancies in transplant recipients. Transplant Proc. 1975;7(2):323-6.
Penn I. Malignant disease in immunodeficient states in man. Recent Results Cancer Res. 1975;(52):96-106.
1974
Penn I. Malignancies in recipients of organ transplants. Johns Hopkins Med J Suppl. 1974;3:211-21.
Penn I. Occurrence of cancer in immune deficiencies. Cancer. 1974;34(3):suppl:858-66.
1973
Halgrimson CG, Penn I, Booth A, Groth C, Putnam CW, Corman J, et al. Eight- to ten-year follow-up in early cases of renal homotransplantation. Transplant Proc. 1973;5(1):787-91.
1972
Penn I, Durst AL, Machado M, Halgrimson CG, S., Bynon J. J, Putman CW, et al. Acute pancreatitis and hyperamylasemia in renal homograft recipients. Arch Surg. 1972;105(2):167-72.
Starzl TE, Groth CG, Kashiwagi N, Putnam CW, Corman JL, Halgrimson CG, et al. Clinical experience with horse antihuman ALG. Transplant Proc. 1972;4(4):491-5.
Penn I, Starzl TE. Malignant tumors arising de novo in immunosuppressed organ transplant recipients. Transplantation. 1972;14(4):407-17.
1971
Starzl TE, Halgrimson CG, Penn I, Martineau G, Schroter G, Amemiya H, et al. Cyclophosphamide and human organ transplantation. Lancet. 1971;2(7715):70-4.

Pages